2
Turn data into knowledge assets Prove viability, efficacy & safety Drive financial return on knowledge capital The e[automateddatascientist] Eagle Genomics knowledge discovery platform utilizes machine learning to transform data to actionable insights that drive scientific decision making. The insight gained from the platform enables quick assessment of product potential, accelerates market entry and mitigates risk. Why use the e[automateddatascientist]? Enable the digital transformation of life sciences R&D Increase productivity, reduce product time to market Boost innovation and turn data into product and IP Proven technology deployed in global consumer goods & pharma organizations “Unilever’s digital data program now processes genetic sequences twenty times faster— without incurring higher compute costs. In addition, its robust architecture supports ten times as many scientists, all working simultaneously.” Pete Keeley, eScience IT Lead for Cloud Solutions, Unilever © 2018 Eagle Genomics | www.eaglegenomics.com Time to insight from months to hours Align R&D innovation with business goals Identify the most compelling research areas to focus investment Reduce the likelihood and limit impact of project failure More credible scientific claims & enhanced brand perception Enable commercialization of data assets Scientific Decision Making Prove the viability, efficacy and safety of products with our AI- augmented knowledge discovery platform, powered by life sciences data. Health, Wellness and Life Sciences organisations are currently failing to turn ever-growing quantities of data into actionable insights that could transform product decision-making; to determine viability and efficacy more quickly, whilst ensuring that products do no harm. In a hyper competitive market environment, failure to address any of these challenges will lead to loss of competitive advantage and market position. Assess data value within relevant context Instantly judge the significance of new data Build and compound the value of knowledge assets Enable effective collaboration around data assets Assess return on proprietary data Map relationship between scientific endeavor & financial return

Scientific Decision Making · “Unilever’s digital data program now processes genetic sequences twenty times faster—without ... efficacy and safety of products with our AI-augmented

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Scientific Decision Making · “Unilever’s digital data program now processes genetic sequences twenty times faster—without ... efficacy and safety of products with our AI-augmented

Turn data into knowledge assets

Prove viability, efficacy & safety

Drive financial return on knowledge capital

The e[automateddatascientist]Eagle Genomics knowledge discovery platform utilizes machinelearning to transform data to actionable insights that drive scientificdecision making. The insight gained from the platform enables quickassessment of product potential, accelerates market entry andmitigates risk.

Why use the e[automateddatascientist]?

• Enable the digital transformation of life sciences R&D

• Increase productivity, reduce product time to market

• Boost innovation and turn data into product and IP

• Proven technology deployed in global consumer goods & pharma organizations

“Unilever’s digital data program now processes genetic sequences twenty times faster— without incurring higher compute costs. In addition, its robust architecture supports ten times as many scientists, all working simultaneously.”

Pete Keeley, eScience IT Lead for Cloud Solutions, Unilever

© 2018 Eagle Genomics | www.eaglegenomics.com

Time to insight from months tohours

• Align R&D innovation with business goals

• Identify the most compelling research areas to focus investment

• Reduce the likelihood and limit impact of project failure

More credible scientific claims & enhanced brand perception

Enable commercialization of data assets

Scientific Decision MakingProve the viability, efficacy and safety of products with our AI-augmented knowledge discovery platform, powered by life sciences data.

Health, Wellness and Life Sciences organisations are currently failingto turn ever-growing quantities of data into actionable insights thatcould transform product decision-making; to determine viability andefficacy more quickly, whilst ensuring that products do no harm. In ahyper competitive market environment, failure to address any ofthese challenges will lead to loss of competitive advantage andmarket position.

• Assess data value within relevant context

• Instantly judge the significance of new data

• Build and compound the value of knowledge assets

• Enable effective collaboration around data assets

• Assess return on proprietary data

• Map relationship between scientific endeavor & financial return

Page 2: Scientific Decision Making · “Unilever’s digital data program now processes genetic sequences twenty times faster—without ... efficacy and safety of products with our AI-augmented

At Eagle Genomics we innovate at the intersection of biology, data science and bioinformatics. The 21stcentury is the age of biology and solutions to the health challenges we face can only be met with thedigital reinvention of life sciences R&D. Our purpose is to advance data science, to drive scientificdiscovery in the fields of human genomics and microbiomics and to equip our customers to solve some ofthe grand challenges of our age. Ultimately we want our software solutions to improve lives.

Eagle Genomics

Our promise to you

We are thought leaders in life sciences smart data management and analysis and are therefore uniquely positioned to meet the complex challenges our customers face

An offer to get you started• A typical (faststart)

engagement comprises of pre-packaged requirements gathering, interpretation and proof of concept

• This will enable business case creation and a return on investment model within 3 months of initial engagement

Eagle Genomics on Azure using Cognitive Services delivers organizations best in class knowledge discovery

© 2018 Eagle Genomics | www.eaglegenomics.com

Microsoft Azure cloud for the genomics era• Platform-as-a-service enables federated scientific decision

making

• Scientific pipeline compute cycle radically compressed

• Enabling microbiome innovation at previously unattainable scale

Microsoft cognitive services enabling intelligent insight• Mapping of complex information and data powered by

cognitive services

• Enriched knowledge discovery with machine learning

• Leveraging comprehensive toolset to operationalize AI for our customers

Best in class data security with Azure• Trusted by global enterprise customers in the personal

care, food, cosmetics and healthcare industries

• Enhanced collaboration facilitated by data accessibility, consistency and scalability

• Facilitating the safe sharing of data and ideas between divisions

Desired Outcomes

Eagle Genomics

• Demonstrable return on investment model across cap-ex and op-ex

• Quantifiable value enhancement of data assets

• Establish data science at the centre of organizational decision making